Emilio Francesco Giunta

1.2k total citations
61 papers, 646 citations indexed

About

Emilio Francesco Giunta is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Emilio Francesco Giunta has authored 61 papers receiving a total of 646 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Oncology, 23 papers in Pulmonary and Respiratory Medicine and 16 papers in Cancer Research. Recurrent topics in Emilio Francesco Giunta's work include Prostate Cancer Treatment and Research (12 papers), Cancer Genomics and Diagnostics (10 papers) and Colorectal Cancer Treatments and Studies (9 papers). Emilio Francesco Giunta is often cited by papers focused on Prostate Cancer Treatment and Research (12 papers), Cancer Genomics and Diagnostics (10 papers) and Colorectal Cancer Treatments and Studies (9 papers). Emilio Francesco Giunta collaborates with scholars based in Italy, United Kingdom and Switzerland. Emilio Francesco Giunta's co-authors include Teresa Troiani, Fortunato Ciardiello, Bruno Daniele, Vincenzo De Falco, Davide Ciardiello, Stefania Napolitano, Giuseppe Luigi Banna, Erika Martinelli, Giuseppe Argenziano and Fortunato Ciardiello and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Emilio Francesco Giunta

58 papers receiving 638 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emilio Francesco Giunta Italy 15 386 210 174 108 96 61 646
Brandon G. Smaglo United States 15 368 1.0× 223 1.1× 146 0.8× 136 1.3× 89 0.9× 54 686
Zhefeng Liu China 14 382 1.0× 137 0.7× 235 1.4× 57 0.5× 73 0.8× 36 615
Changqing Xie United States 14 465 1.2× 165 0.8× 116 0.7× 147 1.4× 183 1.9× 48 745
Alfonso Berrocal Spain 17 399 1.0× 213 1.0× 123 0.7× 84 0.8× 115 1.2× 60 681
Dan Sha China 7 372 1.0× 204 1.0× 210 1.2× 84 0.8× 114 1.2× 16 644
Kailun Fei China 14 481 1.2× 184 0.9× 265 1.5× 68 0.6× 187 1.9× 23 706
Vito Longo Italy 12 284 0.7× 127 0.6× 128 0.7× 65 0.6× 95 1.0× 29 487
Afshin Moradi Iran 14 183 0.5× 216 1.0× 122 0.7× 109 1.0× 83 0.9× 79 640
Imane El Dika United States 13 214 0.6× 207 1.0× 109 0.6× 81 0.8× 75 0.8× 30 573

Countries citing papers authored by Emilio Francesco Giunta

Since Specialization
Citations

This map shows the geographic impact of Emilio Francesco Giunta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emilio Francesco Giunta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emilio Francesco Giunta more than expected).

Fields of papers citing papers by Emilio Francesco Giunta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emilio Francesco Giunta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emilio Francesco Giunta. The network helps show where Emilio Francesco Giunta may publish in the future.

Co-authorship network of co-authors of Emilio Francesco Giunta

This figure shows the co-authorship network connecting the top 25 collaborators of Emilio Francesco Giunta. A scholar is included among the top collaborators of Emilio Francesco Giunta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emilio Francesco Giunta. Emilio Francesco Giunta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Giunta, Emilio Francesco, Nicole Brighi, Giorgia Gurioli, et al.. (2024). 177Lu-PSMA therapy in metastatic prostate cancer: An updated review of prognostic and predictive biomarkers. Cancer Treatment Reviews. 125. 102699–102699. 8 indexed citations
2.
3.
Giunta, Emilio Francesco, et al.. (2024). New-generation androgen receptor signaling inhibitors (ARSIs) in metastatic hormone-sensitive prostate cancer (mHSPC): pharmacokinetics, drug-drug interactions (DDIs), and clinical impact. Expert Opinion on Drug Metabolism & Toxicology. 20(6). 491–502. 4 indexed citations
4.
5.
Giunta, Emilio Francesco, Giuseppe Schepisi, Nicole Brighi, et al.. (2024). An evaluation of talazoparib plus enzalutamide for the treatment of metastatic castration-resistant prostate cancer. Expert Review of Anticancer Therapy. 24(12). 1221–1227. 1 indexed citations
6.
Giunta, Emilio Francesco, Giandomenico Roviello, Vincenza Conteduca, et al.. (2024). Pharmacological treatment landscape of non-metastatic hormone-sensitive prostate cancer: A narrative review on behalf of the meet-URO Group. Critical Reviews in Oncology/Hematology. 204. 104534–104534. 1 indexed citations
7.
Fratino, Lucia, Jerry Polesel, Emilio Francesco Giunta, et al.. (2024). Instrumental activities of daily living in older patients with metastatic prostate cancer: results from the meet-URO network ADHERE prospective study. Scientific Reports. 14(1). 4949–4949.
8.
9.
Giunta, Emilio Francesco, Umberto Malapelle, Antonio Russo, & Ugo De Giorgi. (2023). Blood-based liquid biopsy in advanced prostate cancer. Critical Reviews in Oncology/Hematology. 194. 104241–104241. 2 indexed citations
10.
Cursano, Maria Concetta, Emilio Francesco Giunta, Emanuela Scarpi, et al.. (2023). Impact of Somatic DNA Repair Mutations on the Clinical Outcomes of Bone Metastases from Castration-Resistant Prostate Cancer. International Journal of Molecular Sciences. 24(15). 12436–12436. 3 indexed citations
11.
Messina, Carlo, Emilio Francesco Giunta, Alessio Signori, et al.. (2023). Combining PARP Inhibitors and Androgen Receptor Signalling Inhibitors in Metastatic Prostate Cancer: A Quantitative Synthesis and Meta-analysis. European Urology Oncology. 7(2). 179–188. 22 indexed citations
12.
Banna, Giuseppe Luigi, Alessio Signori, Alessandra Curioni‐Fontecedro, et al.. (2022). Systemic therapy for pre-treated malignant mesothelioma: A systematic review, meta-analysis and network meta-analysis of randomised controlled trials. European Journal of Cancer. 166. 287–299. 5 indexed citations
13.
Ottaviano, Margaret, Emilio Francesco Giunta, Laura Marandino, et al.. (2022). Anorectal and Genital Mucosal Melanoma: Diagnostic Challenges, Current Knowledge and Therapeutic Opportunities of Rare Melanomas. Biomedicines. 10(1). 150–150. 21 indexed citations
14.
Bavetta, Maria Grazia, et al.. (2022). Hepatocellular Carcinoma: Current Therapeutic Algorithm for Localized and Advanced Disease. Journal of Oncology. 2022. 1–14. 9 indexed citations
15.
Giunta, Emilio Francesco, Alfredo Addeo, Alessio Rizzo, & Giuseppe Luigi Banna. (2022). First-Line Treatment for Advanced SCLC: What Is Left Behind and Beyond Chemoimmunotherapy. Frontiers in Medicine. 9. 924853–924853. 8 indexed citations
16.
Personeni, Nicola, Valeria Smiroldo, Emilio Francesco Giunta, et al.. (2021). Tackling Refractory Metastatic Colorectal Cancer: Future Perspectives. Cancers. 13(18). 4506–4506. 14 indexed citations
17.
Giunta, Emilio Francesco, Giacomo Bregni, Andrea Pretta, et al.. (2021). Total neoadjuvant therapy for rectal cancer: Making sense of the results from the RAPIDO and PRODIGE 23 trials. Cancer Treatment Reviews. 96. 102177–102177. 35 indexed citations
18.
Dallio, Marcello, Pietro Paolo Vitiello, Emilio Francesco Giunta, et al.. (2020). Light Alcohol Drinking and the Risk of Cancer Development: A Controversial Relationship. Reviews on Recent Clinical Trials. 15(3). 164–177. 9 indexed citations
19.
Viscardi, Giuseppe, N. Zanaletti, Antonello Sica, et al.. (2019). Atypical haemolytic-uraemic syndrome in patient with metastatic colorectal cancer treated with fluorouracil and oxaliplatin: a case report and a review of literature. ESMO Open. 4(5). e000551–e000551. 14 indexed citations
20.
Napolitano, Stefania, Nunzia Matrone, Giulia Martini, et al.. (2019). Triple blockade of EGFR, MEK and PD-L1 has antitumor activity in colorectal cancer models with constitutive activation of MAPK signaling and PD-L1 overexpression. Journal of Experimental & Clinical Cancer Research. 38(1). 492–492. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brandon G. Smaglo Breakdown of academic impact, for papers by Zhefeng Liu Breakdown of academic impact, for papers by Changqing Xie Breakdown of academic impact, for papers by Alfonso Berrocal Breakdown of academic impact, for papers by Dan Sha Breakdown of academic impact, for papers by Kailun Fei Breakdown of academic impact, for papers by Vito Longo Breakdown of academic impact, for papers by Afshin Moradi Breakdown of academic impact, for papers by Imane El Dika
Rankless by CCL
2026